Summary: Serial serum determinations of the tumour associated antigens carcinoembryonic antigen, tissue polypeptide antigen, CA 19-9, CA 15-3 and CA 125 were performed on 70 patients who were undergoing, or had undergone renal transplantation.The period of observation ranged from 4 days pre-operative to 708 days post-operative, although daily monitoring was usually carried out during the first 14-35 days post-operatively.With the exception of tissue polypeptide antigen, which was analysed with an immunoluminometric assay, all analytes were measured with the Enzymun-Test® System ES-300 using immunoenzymometric assays with colorimetric determination. The interassay coefficients of variation were less than 5% for the immunoenzymometric assays and 8.7% for tissue polypeptide antigen, all values being derived from 20 consecutive assays.Only 8/70 patients with no complications showed normal concentrations for all five analytes. 6/79 patients showed parallel changes of at least three markers. 7/70 patients had transient elevations of at least one marker, whereas 25/70 patients had a continual elevation of CA 125, 9/70 CA 19-9 and 1/70 CA 15-3, although no patient showed evidence of disease. Two patients, each with 2 rejection episodes, showed daily fluctuations up to 100% for all markers, with the exception of carcinoembryonic antigen. There was no correlation between elevated tumour markers and cytomegalovirus infection.° uc on leased into the circulation, thus allowing an early and Despite the vast amount of research on developing specific detection of malignancies. It was seen howin-vitro tests suitable for the early detection of cancer, ever, that the same tumour associated antigens were the lack of diagnostic sensitivity and specificity has expressed and released in non-malignant states,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.